Diabetes Stem Cell Program Launched by The Diabetes & Obesity Center of Excellence and The Institute for Stem Cell and Regenerative Medicine
The Diabetes & Obesity Center of Excellence (DOCE), in partnership with the Institute for Stem Cell and Regenerative Medicine (ISCRM), is actively moving ahead to create the Diabetes Stem Cell Program (DSCP) at UW Medicine Research at South Lake Union. The DSCP is the interface between the DOCE and ISCRM. This collaborative effort will unite investigators and resources across a variety of disciplines in a programmatic effort to develop a cell-based therapy for diabetes.
After a lengthy national and international search, we are pleased to welcome Vincenzo Cirulli MD, PhD and Laura Crisa MD, PhD, as the newest members of the DSCP. Drs. Cirulli and Crisa, along with their Post Doctoral Fellows, Rudolf Pillich and Antonio Jimenez-Caliani, will be joining us the first week of August 2009.
Diabetes & Obesity Center of Excellence Director and Researcher, Michael Schwartz MD, was awarded a one year NIH Instrumentation Grant under the American Recovery and Reinvestment Act (ARRA) program. This award will provide Dr. Schwartz’s group with state-of-the-art equipment to perform energy balance and metabolic phenotyping of rodent models relevant to nutrition, obesity, diabetes and related disorders.
The Diabetes & Obesity Center of Excellence (DOCE) and the Division of Metabolism, Endocrinology & Nutrition, are pleased to welcome two new Acting Associate Professors, Vincenzo Cirulli MD, PhD and Laura Crisa MD, PhD. Dr. Cirulli comes to us from the Department of Pediatrics at the University of California, San Diego. Laura Crisa MD, PhD comes to us from the Department of Molecular and Experimental Medicine at the Scripps Research Institute in La Jolla, CA. Drs. Cirulli and Crisa will be members of the Diabetes Stem Cell Program (DSCP), which is the interface between the DOCE and the Institute for Stem Cell and Regenerative Medicine (ISCRM). This collaborative effort will unite investigators and resources across a variety of disciplines in a programmatic effort to develop a cell-based therapy for diabetes. Drs. Cirulli and Crisa, along with their Post Doctoral Fellows, Rudolf Pillich and Antonio Jimenez-Caliani, will be joining DOCE the first week of August 2009.
UW Medicine at South Lake Union Phase II receives the 2009 AIA Washington Council Civic Design Award
UW Medicine at South Lake Union Phase II was recognized with an AIA Washington Council 2009 Civic Design Award. The Annual AIA|WA Civic Design Awards were held May 14, 2009. Eight projects were honored at the event. Three were given the Citation Award, three received the Merit Award, and two received the Honor Award. UW Medicine at South Lake Union was one of the two Honor Award recipients. The Diabetes & Obesity Center of Excellence is located within the UW Medicine at South Lake Union Phase II complex.
According to the AIA Washington Council Website, “All of the buildings were praised for their transparency which allowed for a connection to the environment and vibrant natural light; the jury further commended the designs for their seamless integration of community purpose with beautiful architecture.”
For additional information regarding the 2009 AIA Washington Council Awards, please see their website at http://www.aiawa.org/CDA09.htm.
David Cummings MD and Karen Foster-Schubert MD receive prestigious Endocrine Society Pfizer International Award
Karen Foster-Schubert and David E. Cummings, both from the Division of Metabolism, Endocrinology and Nutrition, have received the Endocrine Society’s annual Pfizer International Award for Excellence in Published Clinical Research, recognizing the four best clinical research papers published in the Journal of Clinical Endocrinology & Metabolism each year. Their paper is “Acyl and Total Ghrelin Are Suppressed Strongly by Proteins, Weakly by Lipids, and Biphasically by Carbohydrates”. The first author is Dr. Foster-Schubert and the last author is Dr. Cummings. This prestigious award includes a $10,000 cash prize and complimentary transportation, lodging, and attendance at the society’s annual meeting next month, where the authors will be honored.
Dr. Cummings is an investigator at the Diabetes & Obesity Center of Excellence.
The American Diabetes Association awarded Dr. Christiane Hampe a 3 year Basic Science Award for her project entitled “Humoral network in type 1 Diabetes.”
As noted December 1, 2008 in DOM Week:
“Dr. Kim is associate professor of medicine at Harborview Medical Center. A graduate of UC Berkeley and the UCSF School of Medicine, he came to the Department in 1992 for medicine residency and a fellowship in cardiology before joining the faculty. In 2006 he was appointed a Philip and Helen Fialkow Scholar. He currently investigates impairment of endothelial nitric oxide production in diabetes/obesity and the effects of air pollution on vascular inflammation. The professorship was created with a gift from Kenneth Cooper to support development of resources for preventive medicine within thedivision. Dr. Cooper is an international leader in physical fitness and preventive medicine who developed the standard 12-minute fitness test and wrote the renowned1968 book Aerobics. He began his career as an intern at Harborview Medical Center and later became a physician in the Air Force and with NASA.”
On Wednesday November 26, 2008, Dr. Michael Schwartz was featured in the New Scientist Magazine article “Anti Fat Pill Could Help Keep The Weight Off.”
To view the complete article, click here:
The inauguration of the Diabetes & Obesity Center of Excellence at UW Medicine South Lake Union took place on Friday November 14, 2008. There was an afternoon symposium to explore research topics, followed by a poster-viewing reception. The afternoon symposium consisted of the following talks:
1:30 pm: Opening Remarks and Introductions — Dr. Michael W. Schwartz, Dr. Paul G. Ramsey, Dr. William J. Bremner
2:00 pm: Is insulin resistance a vascular condition? The role of nitric oxide and the development of insulin resistance — Dr. Francis Kim
2:30 pm: Diabetes-accelerated atherosclerosis and inflammation – Dr. Karin Bornfeldt
3:00 pm: Keynote Address: The role of inflammation in insulin resistance and type 2 diabetes – Dr. Jerrold Olefsky
4:00 pm: Closing Remarks — Dr. Michael W. Schwartz